Search Results

Containing any of the words

Only of the type

Telmisartan Risk Minimization Activity - New

Ciltacabtagene Autoleucel Risk Minimization Activity - New

SFDA Achieves a Middle East First as Dammam Reference Laboratory Earns Accreditation for PFAS Monitoring in Food News

General Guideline on Regulatory and Scientific Requirements for Biosimilar Approval Regulations

Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma Awareness Article

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events Awareness Article

Pain-related behavior, pain perception and effectiveness of intraosseous local anesthesia (Quicksleeper 5) in pulpotomies of mandibular primary molars Clinical Trial

A PHASE III, RANDOMIZED, OPEN-LABEL STUDY EVALUATING THE EFFICACY AND SAFETY OF GIREDESTRANT IN COMBINATION WITH PHESGO VERSUS PHESGO AFTER INDUCTION THERAPY WITH PHESGO  TAXANE IN PATIENTS WITH PREVIOUSLY UNTREATED HER2-POSITIVE, ESTROGEN RECEPTOR-POSITIVE LOCALLY-ADVANCED OR METASTATIC BREAST CANCER Drug Clinical Trial

An Open Label, Multicenter, Dose Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SBC-102 (Sebelipase Alfa) in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency Drug Clinical Trial

A Randomized, Open-Label, Phase 3 Study of Abemaciclib combined with Standard Adjuvant Endocrine Therapy versus Standard Endocrine Therapy Alone in Patients with High Risk Node Positive Early Stage Hormone Receptor Positive, Human Epidermal Receptor 2 Negative Breast Cancer Drug Clinical Trial